Trial Profile
Phase I/IIA Clinical Study of TUTI-16 in HIV-1 Infected and Uninfected Subjects.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs TUTI 16 (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 11 Jan 2012 Actual end date Apr 2011 added as reported by ClinicalTrials.gov.
- 11 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Mar 2011 Planned end date changed from 1 Aug 2011 to 1 Sep 2011 as reported by ClinicalTrials.gov.